Gordon Treadway
President at Culture Partners
Gordon Treadway active positions
| Companies | Position | Start | End |
|---|---|---|---|
Culture Partners
 Culture Partners Miscellaneous Commercial ServicesCommercial Services Culture Partners engages in the provision of accountability training and consulting services. Its practice areas are accountability, accelerating culture change, employee engagement, execution and implementation, executive team alignment, information technology culture, and leadership development. The company was founded by Roger Connors and Tom Smith in 1989 and is headquartered in Temecula, CA. | President | 2012-12-31 | - |
| Chief Executive Officer | 2015-12-31 | - |
Career history of Gordon Treadway
Former positions of Gordon Treadway
| Companies | Position | Start | End |
|---|---|---|---|
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Sales & Marketing | 2006-12-31 | 2014-02-02 |
Training of Gordon Treadway
| Brigham Young University | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Culture Partners
Culture Partners Miscellaneous Commercial ServicesCommercial Services Culture Partners engages in the provision of accountability training and consulting services. Its practice areas are accountability, accelerating culture change, employee engagement, execution and implementation, executive team alignment, information technology culture, and leadership development. The company was founded by Roger Connors and Tom Smith in 1989 and is headquartered in Temecula, CA. | Commercial Services |
- Stock Market
- Insiders
- Gordon Treadway
- Experience
